Correspondence 0001213900-25-069659 from MAINZ BIOMED N.V. (MYNZ) (CIK 0001874252) (MYNZ)
MAINZ BIOMED N.V. (MYNZ) (CIK 0001874252)
Date: July 31, 2025 · CIK: 0001874252 · Accession: 0001213900-25-069659
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289095
Letter
MAXIM GROUP LLC
300 Park Avenue
New York, New York 10022
July 31, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: Mainz Biomed N.V.
Registration Statement on Form F-1 (Registration No. 333-289095)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), the undersigned, as placement agent in connection with the above referenced Registration Statement relating to the offer and issuance by the Registrant of certain of its securities, hereby joins the Registrant's request that the effective date of the Registration Statement be accelerated so that it shall be declared effective at 8:00 AM Eastern Time on Monday, August 4, 2025, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, we wish to advise you that the placement agent has distributed as many copies of the Preliminary Prospectus, dated July 30, 2025, to investors, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
This is to further advise you that the placement agent has and will continue to comply with Rule 15c2-8 of the Securities Exchange Act of 1934, as amended, with regard to the Preliminary Prospectus and any amended Prospectus.
If you require any additional information with respect to this letter, please contact Ali Panjwani of Pryor Cashman LLP at (212) 326-0820.
Very truly yours,
MAXIM GROUP LLC
Show Raw Text
CORRESP 1 filename1.htm MAXIM GROUP LLC 300 Park Avenue New York, New York 10022 July 31, 2025 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Re: Mainz Biomed N.V. Registration Statement on Form F-1 (Registration No. 333-289095) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the " Securities Act "), the undersigned, as placement agent in connection with the above referenced Registration Statement relating to the offer and issuance by the Registrant of certain of its securities, hereby joins the Registrant's request that the effective date of the Registration Statement be accelerated so that it shall be declared effective at 8:00 AM Eastern Time on Monday, August 4, 2025, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, we wish to advise you that the placement agent has distributed as many copies of the Preliminary Prospectus, dated July 30, 2025, to investors, dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus. This is to further advise you that the placement agent has and will continue to comply with Rule 15c2-8 of the Securities Exchange Act of 1934, as amended, with regard to the Preliminary Prospectus and any amended Prospectus. If you require any additional information with respect to this letter, please contact Ali Panjwani of Pryor Cashman LLP at (212) 326-0820. Very truly yours, MAXIM GROUP LLC By: /s/ Ritesh M. Veera Name: Ritesh M. Veera Title: Co-Head of Investment Banking